Enzyme company Dyadic International, Inc. signed a collaboration agreement with Compagnie Industrielle de la Matière Végétale (CIMV), a developer of processes for the production of biofuels and bio-based chemicals, to commercialize second-generation biofuel and bio-based chemical technology.
Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 microorganism, which enables the development and large scale manufacture of low-cost enzymes and other proteins for diverse market opportunities. The C1 expression system can also be used to screen for the discovery of novel genes.
CIMV’s patented approach of separating the three main components of plant material allows both production of high quality cellulose and hemicellulose, especially well-suited for the enzymatic process, and Biolignin, a pure form of lignin that may be sold commercially as a high value, environmentally friendly alternative to petroleum-derived chemicals.
Under the collaboration agreement, Dyadic and CIMV will work together to develop more efficient, fully integrated processes to produce environmentally low impact biofuels and bio-based chemicals. Dyadic anticipates supplying enzymes to CIMV’s planned 2015 demonstration plant, as well as licensing its C1 technology for on-site production of enzymes at CIMV’s future commercial scale plants.
To complete the value chain from biomass to bioethanol, CIMV is also collaborating with Taurus Energy AB, a leading developer of yeast technology to turn cellulosic sugar into bioethanol, and for its international development with Pierson Capital, a leading developer of major infrastructure, transportation and energy programs in the emerging markets of China, Africa and Latin America.